autologous bone marrow-derived stem cells (Igenomix)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameautologous bone marrow-derived stem cells (Igenomix)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsUterine Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesIgenomix
China Registration ClassN/A

Develop Information

Active CompaniesIgenomix
Inactive CompaniesN/A
Active IndicationsUterine Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A